Quantification of the impact of enzyme‐inducing antiepileptic drugs on irinotecan pharmacokinetics and SN‐38 exposure

E-ISSN： 1552-4604|55|11|1303-1312

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.11, 2015-11, pp. : 1303-1312

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quantification of the impact of enzyme‐inducing antiepileptic drugs on irinotecan pharmacokinetics and SN‐38 exposure

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 91-2700, Iss. 11, 2015-11 ,pp. : 1303-1312

John Wiley & Sons Inc

Access to resources Recommend Favorite

Passage of irinotecan and its active metabolite, SN‐38, into human milk

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 41, Iss. 5, 2016-10 ,pp. : 579-582

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized phase 2 study of pegylated SN‐38 (EZN‐2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer

CANCER, Vol. 119, Iss. 24, 2013-12 ,pp. : 4223-4230

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiepileptic drugs and bone disease

By Pack Alison

Clinical Review in Bone and Mineral Metabolism, Vol. 2, Iss. 2, 2004-06 ,pp. : 159-165

Humana Press, Inc

Access to resources Recommend Favorite

Mechanisms of action of antiepileptic drugs

By Cook Aaron M Bensalem-Owen Meriem K

Therapy, Vol. 8, Iss. 3, 2011-05 ,pp. : 307-313

Future Medicine

Access to resources Recommend Favorite